Colposcopy in Inflammatory PAP SMEARS
Dr Aakanksha agarwal, Dr Beena
Bhatnagar, Dr Priyanka Suhag
Journal Title:GLOBAL JOURNAL FOR RESEARCH ANALYSIS
Cervical is the second most common cancer in the world and the leading cause of death. Frequency and mortatilty are
significantly reduced by screening through cytological Papanicolau test.However PAP test has low sensitivity and a high negative rate of 9-40%.
Epithelial abnormalities on PAP test can be managed according to ACCP guidelines. However for management of inflammatory smears there
are no such algorithms available. The incidence of inflammatory PAP smears is very high 14-19%. and subjecting each patient to colposcopy and
HPV DNA testing might become costly. This study was done to evaluate inflammatory PAP smears with colposcopy and directed biopsy to find
out any premalignant changes in the cervix and whether colposcopy should be done to help triage these women.
MATERIAL AND METHOD
100 women were screened at NIMS Hospital with PAP smear. However only those women who had inflammatory smears were subjected to
colposcopy and directed biopsies.
Out of 91 patients , 28 women (30%) had normal colposcopy,and 63 women(70%) had abnormal colposcopy of which 6.5% had polyp, 15.38%
had CIN1, 3.29% had CIN 2, 3.29% had CIN 3 and 1.09% had invasive cancer.
Nearly 70% women had abnormal colposcopy with PAP smear showing inflammatory smear. Hence a large no of women with abnormal
colposcopy and CIN (around 10%) would be missed if inflammatory PAP smears are not evaluated further.